A Study to Evaluate the Use of Organoids to Advance Precision Medicine in Bladder Cancer


About this study

The purpose of this study is to develop patient-derived organoid cultures of urothelial carcinoma from non-invasively obtained urine samples and to characterize the histological, molecular and functional features of patient-derived organoids.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria: 

  • Adults ≥ 18 years of age.
  • Bladder tumor on pre-biopsy cystocopy.
  • High suspicion for bladder cancer.

​​​​​​​Exclusion Criteria: 

  • Under 18 years of age.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Igor Frank, M.D.

Open for enrollment

Contact information:

Kathryn Barthels B.S.

(507) 538-5772


More information


Publications are currently not available

Mayo Clinic Footer